• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清甲胎蛋白和人绒毛膜促性腺激素作为睾丸癌术后放疗和/或化疗疗效的标志物。

Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.

作者信息

Schultz H, Sell A, Nørgaard-Pedersen B, Arends J

出版信息

Cancer. 1978 Nov;42(5):2182-6. doi: 10.1002/1097-0142(197811)42:5<2182::aid-cncr2820420515>3.0.co;2-7.

DOI:10.1002/1097-0142(197811)42:5<2182::aid-cncr2820420515>3.0.co;2-7
PMID:82474
Abstract

Human alpha1-fetoprotein (AFP) and chroiongonadotropin (hCG) have been studied in 67 patients with malignant germ cell neoplasia of the testis admitted to the Radium Centre, Aarhus Municipal Hospital within an 18 month period. In 34 patients with nonseminoma, AFP was elevated in 35% of cases and hCG in 38% of cases. Nonseminoma patients who presented with or developed distant metastases showed a significantly higher incidence of elevated tumor markers than patients with local or regional disease. In patients with distant metastases monitoring of AFP and/or hCG was a most sensitive and reliable indicator of disease activity. In the management of such patients these tests are as important as clinical and x-ray examinations.

摘要

在18个月的时间里,对奥胡斯市立医院镭中心收治的67例睾丸恶性生殖细胞瘤患者的人α1-甲胎蛋白(AFP)和绒毛膜促性腺激素(hCG)进行了研究。在34例非精原细胞瘤患者中,35%的病例AFP升高,38%的病例hCG升高。出现或发生远处转移的非精原细胞瘤患者肿瘤标志物升高的发生率明显高于局部或区域疾病患者。在远处转移患者中,监测AFP和/或hCG是疾病活动最敏感和可靠的指标。在这类患者的治疗中,这些检查与临床和X线检查同样重要。

相似文献

1
Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.血清甲胎蛋白和人绒毛膜促性腺激素作为睾丸癌术后放疗和/或化疗疗效的标志物。
Cancer. 1978 Nov;42(5):2182-6. doi: 10.1002/1097-0142(197811)42:5<2182::aid-cncr2820420515>3.0.co;2-7.
2
Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.血清甲胎蛋白和人绒毛膜促性腺激素在睾丸肿瘤治疗中的应用
Natl Cancer Inst Monogr. 1978 Dec(49):215-7.
3
Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.血清甲胎蛋白和人绒毛膜促性腺激素在非精原细胞性生殖细胞睾丸癌诊断及治疗中的应用
N Engl J Med. 1976 Nov 25;295(22):1237-40. doi: 10.1056/NEJM197611252952207.
4
[Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].[睾丸的生物标志物与生发肿瘤。绒毛膜促性腺激素和甲胎蛋白检测的价值与局限性]
J Urol (Paris). 1988;94(8):393-6.
5
The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors.
Cancer. 1976 Jan;37(1):215-9. doi: 10.1002/1097-0142(197601)37:1<215::aid-cncr2820370131>3.0.co;2-l.
6
Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.睾丸精原细胞瘤患者血清及肿瘤细胞中的人绒毛膜促性腺激素(HCG)和甲胎蛋白(AFP):一项前瞻性研究。
Cancer. 1978 Dec;42(6):2768-72. doi: 10.1002/1097-0142(197812)42:6<2768::aid-cncr2820420636>3.0.co;2-z.
7
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.精原细胞瘤患者的血清甲胎蛋白和人绒毛膜促性腺激素
J Urol. 1980 Oct;124(4):472-8. doi: 10.1016/s0022-5347(17)55500-7.
8
The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours.甲胎蛋白和人绒毛膜促性腺激素β在睾丸肿瘤治疗中的价值。
Br J Urol. 1978 Dec;50(7):605-8. doi: 10.1111/j.1464-410x.1978.tb06222.x.
9
Serum markers in testicular tumors.睾丸肿瘤中的血清标志物。
J Urol. 1979 Jan;121(1):51-3. doi: 10.1016/s0022-5347(17)56658-6.
10
The role of biologic tumor markers in testicular cancer.生物肿瘤标志物在睾丸癌中的作用。
Cancer. 1980 Apr 15;45(7 Suppl):1755-61.

引用本文的文献

1
The detection and evaluation of human tumor metastases.人类肿瘤转移的检测与评估。
Cancer Metastasis Rev. 1983;2(4):351-74. doi: 10.1007/BF00048567.
2
Tumour-marker levels and prognosis in malignant teratoma of the testis.睾丸恶性畸胎瘤的肿瘤标志物水平与预后
Br J Cancer. 1980 Dec;42(6):850-5. doi: 10.1038/bjc.1980.332.
3
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.转移性乳腺癌治疗反应的客观生化评估:一项对临床数据进行外部审查的研究
Br J Cancer. 1990 Jan;61(1):126-32. doi: 10.1038/bjc.1990.26.